TABLE 2

Effect of Vitamin D Supplementation on RSS at 18 Months in Intention-To-Treat Analysis

Placebo (n = 310)Vitamin D (n = 321)P
Range 0–10 0–3 — 
Median (IQR) 0 (0–1) 0 (0–0.5) — 
Mean (95% CI) 0.46 (0.36 to 0.56) 0.35 (0.28 to 0.42) .086 
Rickets, n (%)    
 RSS ≤ 1.5 293 (94.5) 304 (94.7) — 
 RSS >1.5 17 (5.5) 17 (5.3) — 
Risk of rickets, OR (95% CI) 1.0 (reference) 0.96 (0.48 to 1.92) .917 
RSS, mean (95% CI)    
 Calcium <300 mg/day (n = 265) 0.57 (0.37 to 0.77) 0.39 (0.28 to 0.50) .106 
 Calcium ≥ 300 mg/day (n = 270) 0.44 (0.31 to 0.57) 0.29 (0.20 to 0.39) .081 
Placebo (n = 310)Vitamin D (n = 321)P
Range 0–10 0–3 — 
Median (IQR) 0 (0–1) 0 (0–0.5) — 
Mean (95% CI) 0.46 (0.36 to 0.56) 0.35 (0.28 to 0.42) .086 
Rickets, n (%)    
 RSS ≤ 1.5 293 (94.5) 304 (94.7) — 
 RSS >1.5 17 (5.5) 17 (5.3) — 
Risk of rickets, OR (95% CI) 1.0 (reference) 0.96 (0.48 to 1.92) .917 
RSS, mean (95% CI)    
 Calcium <300 mg/day (n = 265) 0.57 (0.37 to 0.77) 0.39 (0.28 to 0.50) .106 
 Calcium ≥ 300 mg/day (n = 270) 0.44 (0.31 to 0.57) 0.29 (0.20 to 0.39) .081 

Dietary calcium was available for 268 children in the placebo (n = 126 with calcium <300 mg/day and n = 142 with calcium ≥ 300 mg/day) and 267 children in the vitamin D group (n = 139 with calcium <300 mg/day and n = 128 with calcium ≥ 300 mg/day). OR, odds ratio; —, not applicable.

Close Modal

or Create an Account

Close Modal
Close Modal